Post #1144257: The US Food and Drug Administration could decide…
The US Food and Drug Administration could decide this week whether to grant accelerated approval to the experimental Alzheimer's drug lecanemab, according to Eisai and Biogen, the companies that make the drug.

The US Food and Drug Administration could decide this week whether to grant accelerated approval to the experimental Alzheimer's drug lecanemab, according to Eisai and Biogen, the companies that make the drug.

https://foxdeo.com/1Y0e.tnk

সব প্রদর্শন করুন @cnn

আপডেট

Popular now

Explore